Bionano Genomics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BNGO and other ETFs, options, and stocks.About BNGO
Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on the genome analysis space. The firm engages in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline cytogenetics.
CEORobert Erik Holmlin
CEORobert Erik Holmlin
Employees100
Employees100
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded2003
Founded2003
Employees100
Employees100
BNGO Key Statistics
Market cap15.57M
Market cap15.57M
Price-Earnings ratio-0.10
Price-Earnings ratio-0.10
Dividend yield—
Dividend yield—
Average volume174.17K
Average volume174.17K
High today—
High today—
Low today—
Low today—
Open price$1.57
Open price$1.57
Volume0.00
Volume0.00
52 Week high$22.80
52 Week high$22.80
52 Week low$1.45
52 Week low$1.45
Stock Snapshot
With a market cap of 15.57M, Bionano Genomics(BNGO) trades at $1.58. The stock has a price-to-earnings ratio of -0.10.
On 2025-12-18, Bionano Genomics(BNGO) stock opened at $1.57, reached a high of —, and a low of —.
The Bionano Genomics(BNGO)'s current trading volume is 0, compared to an average daily volume of 174.17K.
In the last year, Bionano Genomics(BNGO) shares hit a 52-week high of $22.80 and a 52-week low of $1.45.
In the last year, Bionano Genomics(BNGO) shares hit a 52-week high of $22.80 and a 52-week low of $1.45.
People also own
Based on the portfolios of people who own BNGO. This list is generated using Robinhood data, and it’s not a recommendation.